Globally, rotavirus is the leading cause of diarrhea-related hospitalizations and deaths among young children, but the burden of rotavirus disease in Indonesia is poorly documented. From January through December 2006, we conducted prospective surveillance (inpatient and outpatient) among children aged !5 years at 6 hospitals in 6 provinces of Indonesia, using standardized methodology. Of 2240 enrolled children hospitalized for diarrhea, 1345 (60%) were rotavirus positive. Of 176 children enrolled in outpatient clinics in 3 hospitals, 73 (41%) were rotavirus positive. Among children hospitalized for diarrhea, dehydration was more common among those who tested positive for rotavirus than among those who did not (91% vs 82%; ), as was P ! .05 vomiting (86% vs 67%;
years, with 180% of these deaths occurring in developing nations [1] . Furthermore, rotavirus infection causes 2.1 million hospitalizations, 25 million outpatient visits, and 111 million episodes of diarrhea worldwide annually [2] . Surveillance of rotavirus in several countries in the Asian region has found rotavirus to be associated with 30%-70% of diarrhea-related hospitalizations among children [3, 4] .
In Indonesia, few longitudinal studies on the burden of rotavirus disease have been conducted since the 1970s [5] [6] [7] . These older studies used various methodologies and may no longer reflect the etiologies of acute diarrhea in Indonesia today. The annual number of diarrhea-related deaths among children in Indonesia has decreased during the past 20 years, largely because of the successful use of oral rehydration salt. Furthermore, the incidence of bacterial gastroenteritis has decreased because of improvements in sanitation, hygiene, and the availability of antibiotics, which would have had little effect on the rates of rotavirus infection.
To reduce the burden of rotavirus gastroenteritis, ro- tavirus vaccines have been developed and introduced for routine immunization in several countries in the Americas and Europe. In Indonesia, a lack of data on rotavirus burden and circulating strains has led to poor recognition of the magnitude of the problem and low prioritization of rotavirus vaccines as a prevention strategy [8] . To inform a future decision about rotavirus vaccine introduction in Indonesia, we conducted standardized surveillance for severe rotavirus diarrhea and circulating rotavirus strains in 6 health care facilities throughout Indonesia as part of the Asian Rotavirus Surveillance Network.
MATERIALS AND METHODS
This study followed guidelines laid out in a generic protocol for rotavirus surveillance published by the World Health Organization; the protocol was designed to standardize surveillance efforts in different countries [9] . Population and sample. The study population consisted of all children aged !5 years who presented with acute diarrhea from January through December 2006 at any of 6 teaching hospitals. The participating hospitals are located in 6 different provinces of Indonesia, on the islands of Sumatra, Java, Bali, and West Nusa Tenggara (Figure 1 ). The hospitals were Muhammad Hussein Hospital (Palembang, South Sumatra), Cipto Mangunkusumo Hospital (Jakarta, Capital City Special Territory), Hasan Sadikin Hospital (Bandung, West Java), Sardjito Hospital (Yogyakarta, Yogyakarta Special Territory Province), Sanglah Hospital (Denpasar, Bali), and Mataram Hospital (Mataram, West Nusa Tenggara).
Inpatients. All children aged !5 years who were admitted to the participating hospitals with a primary diagnosis of diarrhea were screened for study eligibility. Acute diarrhea was defined as у3 loose stools within 24 h and for a duration of !2 weeks [10] . A standardized clinical form was completed to obtain detailed information on the date of admission, age and sex of the patient, nutritional status, previous treatment, status of dehydration, symptoms of illness, and final diagnosis. A fresh fecal specimen was obtained from enrolled children within 24 h after admission, was placed in a clean container, and was stored at 4ЊC-8ЊC until laboratory testing for rotavirus.
Outpatients. Children aged !5 years who received treatment at outpatient clinics for acute diarrhea (as defined above) in 1 of 3 participating hospitals-Hasan Sadikin Hospital, Sardjito Hospital, and Mataram Hospital-were enrolled. A standardized clinical form similar to the one described above was completed.
Fecal samples were collected at presentation by a nurse or at home within 2 days after the clinic visit by parents or caretakers, who were given small containers for that purpose. Samples were sent to the hospital immediately or were kept in the refrigerator until the next day.
Laboratory examination. Stool specimens were transported in refrigerated boxes either to the Microbiology Laboratory, Gadjah Mada University, Faculty of Medicine, Yogyakarta (specimens from Sardjito, Sanglah, and Mataram hospitals), or to the Biofarma Laboratory, West Java (specimens from Muhammad Hussein, Cipto Mangunkusumo, and Hasan Sadikin hospitals). In the laboratory, the sample was aliquoted and stored at Ϫ70ЊC. Rotavirus was detected using an enzyme immunoassay (Dakopatts; Dako International) in accordance with the manufacturer's instructions. All rotavirus-positive stool specimens were sent to the Gadjah Mada University Laboratory for rotavirus strain characterization. Forty randomly selected strains from each participating hospital (240 in total) were typed during the study period. Ethical considerations. This study was approved by the Ethical Committee of Research in Medical Health at Faculty of Medicine, Gadjah Mada University, and by PATH (Seattle, Washington). Informed consent was obtained from parents or caretakers of eligible children before enrollment in the study.
RESULTS
Hospital-based surveillance. From January through December 2006, a total of 2870 children aged !5 years were hospitalized for acute diarrhea in the 6 participating hospitals. Of these, 2307 children (80%) were enrolled in this study. Stool specimens were tested for 2240 (97%) of all children enrolled. The remaining 67 children either were discharged before a stool sample was obtained or provided an inadequate amount of stool specimen for testing. Of the 2240 stool samples tested, 1345 (60%) were positive for rotavirus. The percentage of children whose samples tested positive for rotavirus ranged from 39% to 67% at the different study sites (Table 1) . Of the enrolled children, 2 died as a result of severe diarrhea (both were rotavirus negative) and another 7 died of causes other than diarrhea.
The percentage of rotavirus-positive cases was high in all age groups but was highest among children aged 6-11 months (64%) and 12-23 months (67%). We found an unexpectedly high prevalence of rotavirus (32%) among infants aged !3 months. Children aged !2 years accounted for 1185 (88%) of the 1345 inpatients with rotavirus-positive diarrhea during the study period. The median age of enrolled children and of children with rotavirus-positive diarrhea was 11 months. Overall, male individuals were more likely to be hospitalized for diarrhea than were female individuals (60% vs 40%), but this sex difference was not statistically significant between rotavirus-positive and rotavirus-negative children. Rotavirus-positive children were more likely to experience dehydration (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.7-2.9) and vomiting (OR, 3.0; 95% CI, 2.4-3.6) and were less likely to have bloody diarrhea (OR, 0.3; 95% CI, 1.7-4.6) than were rotavirus-negative children. The prevalence of fever or mucus in the stool was not significantly different between rotavirus-positive and rotavirus-negative patients. Before hospitalization, 61% of children who tested positive for rotavirus had received oral rehydration salt, 28% had received antibiotics, 17% had received antiemetics, and 14% had received antidiarrheal agents ( Table  2) .
Rotavirus infection occurred year-round at all sites, with a peak during the colder months of June and July, when the rotavirus prevalence rose to 70%-75%, after which the prevalence steadily decreased until December (33%) (Figure 2 )
Outpatient surveillance. Three of the participating hospitals also enrolled children who presented with diarrhea for outpatient care. Of 27, 29, and 120 stool specimens collected from outpatients in Hasan Sadikin Hospital, Sardjito Hospital, and Mataram Hospital, respectively, 11 (41%), 3 (10%), and 59 (49%) tested positive for rotavirus (Table 1 ). Similar to the findings among hospitalized patients, the majority of outpatient rotavirus cases (86%) occurred in children aged !24 months, and rotavirus prevalence increased in the months of May through July. Among the outpatients, the 73 rotavirus-positive children were more likely to present with vomiting (71% vs 34%; OR, 4.8; 95% CI, 2.5-9.2) and dehydration (69% vs 26%; Genotyping. Molecular characterization was performed on 240 specimens that were positive for rotavirus by enzyme immunoassay, to determine G and P genotypes. G genotypes of rotavirus were detected for 199 (83%) of the samples. The majority of strains had genotypes G1 and G9, which accounted for 73 (30%) and 69 (29%) of the 240 samples, respectively, followed by G2, which accounted for 34 specimens (14%). Other genotypes included G3 (0.4%) and G4 (0.4%). The remaining samples were mixed types (9%) ( Figure 3A) . Of the 240 samples, 189 (79%) were successfully P genotyped. P [4] and P [8] antigens were present in 31 (16%) and 33 (17%) of the 189 typed strains, respectively, but an unexpectedly high prevalence (105 [56%] of 189) of genotype P [6] was detected. Mixed infections and untypeable infections accounted for 9% and 21% of samples, respectively ( Figure 3B ). The median age of children infected with P [6] genotype strains was the same as those infected with strains of other P types (11 months).
Both G and P genotypes were established for 123 (51%) of the 240 rotavirus-positive samples. G1P [6] and G9P [6] accounted for 34% and 21% of samples, respectively. Other genotypes included G2P [4] (17%), G1P [8] (11%), and G9P [8] (9%). The remaining genotypes were G1P [4] , G2P [6] , G9P [4] , and G3P [4] , which accounted for 2%, 3%, 2%, and 1%, respectively ( Figure 4) .
DISCUSSION
This study demonstrates that rotavirus infection is the most common cause of severe acute diarrhea among children aged the children who presented with diarrhea at the outpatient clinics. The majority (88%) of all cases of rotavirus disease occurred in children aged !2 years. Rotavirus-positive gastroenteritis was associated with more vomiting and dehydration, compared with rotavirus-negative gastroenteritis. Our study found a high prevalence of P [6] type strains-which were predominately the relatively unusual G1P [6] and G9P [6] strainsand untypeable strains. The currently available vaccines do not contain G9 or P [6] antigens, so these results highlight the importance of continued strain monitoring in Indonesia and additional laboratory efforts to type strains before and after vaccine introduction, to measure vaccine effectiveness against all strains.
Previous studies conducted in Indonesia in the late 1970s detected rotavirus in 15% of patients with mild diarrhea and up to 38% of children with severe acute diarrhea. These results are considerably lower than both our initial findings from 3 sites (57%) and our current findings [3, [5] [6] [7] . A recent study reported that the overall prevalence of rotavirus among children aged !5 years who seek care for diarrhea in Indonesia was 45.5% [11] , but the results of that study are difficult to compare with those of our study, because the age groups were a little different, and outpatient visits were included with hospitalizations. Reasons for the increased prevalence of rotavirus diarrhea in recent years include the use of more-sensitive diagnostic tests and decreases in the number of bacterial and parasitic gastrointestinal infections, as a result of improvements in sanitation and water safety, which would reduce the frequency of all-cause diarrhea but increase the proportion of disease caused by rotavirus.
Very few data have been collected on children who present with diarrhea for outpatient care in Asia. A community-based study in Thailand found that 12% of children with diarrhea at a clinic tested positive for rotavirus, whereas the percentage of children hospitalized with acute diarrhea who tested positive for rotavirus was 43% [12] . The percentage who tested positive for rotavirus in our study was high, compared with that in the Thai study and also with reported prevalences of 10%-20% among outpatients in the United States and Chile [13, 14] . Our findings are nonetheless consistent with the general finding that the prevalence of rotavirus among hospitalizations for diarrhea is higher than that among episodes of milder diarrhea treated in clinics.
Our findings confirm that children aged !3 months are less likely to have rotavirus diarrhea, which is likely to be partly but not exclusively because of transplacental neutralizing immunoglobulin G antibodies and immunoglobulin A in breast milk. Human breast milk also contains several components, including milk mucin, that have been shown to inhibit rotavirus replication and infection by binding to the virus [15] . One study showed that exclusive breast-feeding provides better protection against severe rotavirus infection than partial or no breast-feeding [16] . Furthermore, a longitudinal study involving US children showed a reduced risk of diarrhea among those who were mostly breast-fed during the first 6 months of life [17] .
Countries with tropical climates usually show little seasonal variation in rotavirus, compared with those with temperate climates [12, 18] . We found that rotavirus-positive diarrhea occurred year-round but that there was an apparent increase in rotavirus prevalence in the cool, dry season. This is consistent with our previous study in 2001-2004 that showed a clear seasonal trend of rotavirus infection occurring in the dry season (authors' unpublished data). A study in Myanmar also reported that rotavirus infection was highest during the cool, dry season and decreased in the hot, dry and the hot, wet seasons [19] .
The increased frequency of vomiting and dehydration in rotavirus infection may pose challenges to the administration of oral rehydration salt and may increase reliance on intravenous fluid therapy, thus leading to higher treatment costs. Cost estimation from one of our studies revealed that the rotavirusassociated economic burden from a health care system perspective was US$14.536 million per year (US$3.46 per birth annually) [20] . A substantial proportion of children with rotavirus diarrhea received antibiotics, antivomiting agents, and antidiarrheal agents before they visited the hospital. However, almost 40% of children with diarrhea had not received oral rehydration salt, which is the primary treatment for any dehydrating diarrheal illness, which emphasizes the need for education among parents and primary health care providers about appropriate initial treatment for watery diarrhea.
Overall, P [6] was the most common P type, accounting for 56% of the strains typed. P [6] strains have been reported to be very common among neonates in Bangladesh [21] ; they were also found in 29 (21%) of 137 children of all ages in India [22] . In 1996-1999, P [6] strains were reported to be the most predominant P type, in association with G1 and G3 types, in a survey of circulating strains in Africa [23] .
The globally common genotypes G1P [8] and G2P [4] were not represented strongly in this study and accounted for only 11% and 17% of all strains, respectively. Also, the genotypes G3 and G4 were found only in Yogyakarta, at low prevalences (0.4% each). These findings are in contrast to those of a study conducted in 2001-2004 that showed that G1P [8] represented 62.5% of all strains in Indonesia (authors' unpublished data). The results also differ from those of an older study in Yogyakarta that found that the 4 globally common G types (G1, G2, G3, and G4) were predominant [24] . The finding of a high proportion of G9 in our study corresponds with recent reports that G9 is an emerging serotype in Indonesia [11] and worldwide [23, 25, 26] . Of interest, genotype G9 was found to be predominant in Palembang and Mataram, where rotavirus prevalence was highest.
A high percentage of strains were untypeable (21%), perhaps because of a slight mismatch between primers and strains. Additional laboratory studies will be needed to assess whether these untypeable strains represent G3 and G4 genotypes or perhaps unusual genotypes.
Both the monovalent attenuated human rotavirus vaccine and the pentavalent human-bovine rotavirus reassortant vaccine have demonstrated good efficacy against types G1-G4 and G9. However, with the exception of G2P [4] , the G types are frequently in combination with P [8] , which is the VP4 protein contained in both vaccines, and this will elevate vaccine efficacy against heterologous G types [27] [28] [29] . Although trial data suggest some efficacy of both vaccines against strains comprising G and P types not present in the vaccines, the degree of protection afforded against heterologous strains, such as G9P [6] found in this study, remains unclear.
Overall, our results highlight the high burden of rotavirus disease, the changing diversity of rotavirus strains circulating in Indonesia by location and year, and the currently high prevalence of globally unusual strains. Although the overall disease burden in Africa and Asia is well recognized, the World Health Organization is waiting for the results of vaccine clinical trials in poorer countries of these regions before they will extend the current recommendations for the routine use of available rotavirus vaccines in the Americas and Europe. Studies have shown that, in Asia, rotavirus vaccines are highly cost-effective and are projected to have a large impact on the burden of severe rotavirus gastroenteritis [30] . Moreover, as a GAVI Alliance-eligible country, Indonesia should qualify for a large subsidy for the vaccine cost for a period of 5 years.
To complement this study, research on the economic burden of rotavirus in Indonesia would further support policy makers in making a decision about the introduction of rotavirus vaccine, by helping to assess the relative affordability of the new rotavirus vaccines. Finally, raising community awareness about rotavirus infection and rotavirus vaccines will be important in complementing primary strategies for reducing the disease bur-den. Recent qualitative research has shown a low awareness of rotavirus disease among policy makers, health care practitioners, and the community in Indonesia [8] . This suggests that, in addition to epidemiological and laboratory data, educational campaigns need to be targeted at the medical and nonmedical communities, to increase awareness about the danger of rotavirus infection and to garner broad support from these groups before vaccine introduction.
